Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

306
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
306
MicroRNAs01:22

MicroRNAs

3.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

23.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition.

Journal of autoimmunity·2026
Same author

Combined immunosuppressive therapy in systemic sclerosis-associated interstitial lung disease: Phenotypes matter.

Autoimmunity reviews·2026
Same author

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis.

Frontiers in pharmacology·2026
Same author

Modulation of proinflammatory but not regulatory cytokines by in vitro JAK inhibition in peripheral blood B-cells of patients with psoriatic arthritis.

Journal of dermatological science·2026
Same author

Achievement and Maintenance of Remission with Upadacitinib in Patients with Moderate-to-Severe Rheumatoid Arthritis in Italy: 1-Year Data from UPHOLD, a Prospective Real-World Observational Study.

Rheumatology and therapy·2026
Same author

Natural language processing to intercept rheumatoid and psoriatic arthritis from clinical notes in the Emergency Department.

Therapeutic advances in musculoskeletal disease·2026
Same journal

Atypical Wiskott-Aldrich syndrome presenting with normal platelet volume and end-stage renal disease: from misdiagnosis as ITP to combined transplantation.

Journal of translational autoimmunity·2026
Same journal

Corrigendum to "Data-driven classification of primary Sjögren's syndrome: From cluster analysis to clinical immune phenotypes and predictive biomarkers" [J. Transl. Autoimmun. 12 (2026) 100338].

Journal of translational autoimmunity·2026
Same journal

Corrigendum to 'Divergent trajectories of inflammatory bowel disease in East, South, South-East and Central Asia: A comprehensive GBD 2021 analysis' [J. Transl. Autoimmun. 11 2025 100325].

Journal of translational autoimmunity·2026
Same journal

The clinical profile of systemic sclerosis without a 'scleroderma pattern' at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of Rheumatology.

Journal of translational autoimmunity·2026
Same journal

SM03, a non-depleting anti-CD22 antibody, modulates B cell activation and immune crosstalk to attenuate autoimmunity.

Journal of translational autoimmunity·2026
Same journal

Serum pepsinogen Ⅰ and the pepsinogen Ⅰ/Ⅱ ratio as a non-invasive predictive marker for autoimmune metaplastic atrophic gastritis.

Journal of translational autoimmunity·2026
See all related articles

Related Experiment Video

Updated: Dec 13, 2025

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

1.6K

MicroRNAs in ankylosing spondylitis: Function, potential and challenges.

Francesca Motta1, Maria Cristina Carena2,3, Carlo Selmi1,4

  • 1Division of Rheumatology and Clinical Immunology, Humanitas Research Hospital, IRCCS, Rozzano, Milan, Italy.

Journal of Translational Autoimmunity
|August 4, 2020
PubMed
Summary
This summary is machine-generated.

MicroRNAs (miRNAs) are key epigenetic regulators in Ankylosing Spondylitis (AS) pathogenesis. This study clarifies their role in inflammation, bone formation, and T-cell function, highlighting therapeutic potential.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

819
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.8K

Related Experiment Videos

Last Updated: Dec 13, 2025

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
04:47

Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

Published on: October 27, 2023

1.6K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

819
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.8K

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Ankylosing Spondylitis (AS) is a chronic inflammatory arthritis with complex etiology.
  • Epigenetic mechanisms, including microRNAs (miRNAs), link genetic predisposition and environmental factors in AS.
  • MicroRNAs are crucial regulators of gene expression involved in both physiological and pathological processes.

Purpose of the Study:

  • To elucidate the specific roles of microRNAs in the pathogenesis of Ankylosing Spondylitis.
  • To investigate the involvement of miRNAs in key AS processes: inflammation, aberrant bone formation, and T-cell dysfunction.
  • To identify the signaling pathways regulated by miRNAs in AS.

Main Methods:

  • Review and synthesis of current literature on microRNA involvement in Ankylosing Spondylitis.
  • Analysis of miRNA-mediated regulation of inflammation, osteogenesis, and T-cell responses.
  • Examination of miRNA interactions with critical signaling pathways such as Wnt, BMP, and TGFβ.

Main Results:

  • MicroRNAs significantly contribute to the inflammatory processes observed in AS.
  • Specific miRNAs are implicated in regulating new bone formation, a hallmark of AS pathology.
  • MicroRNAs modulate T-cell function, influencing the immune response in AS pathogenesis.
  • miRNAs target and regulate key signaling pathways involved in AS development.

Conclusions:

  • MicroRNAs are pivotal epigenetic regulators in Ankylosing Spondylitis pathogenesis.
  • Understanding miRNA roles offers insights into AS mechanisms, including inflammation and bone remodeling.
  • MicroRNAs represent a promising avenue for future therapeutic strategies in AS treatment.